Compare IDYA & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | KFY |
|---|---|---|
| Founded | 2015 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.7B |
| IPO Year | 2019 | 1998 |
| Metric | IDYA | KFY |
|---|---|---|
| Price | $38.85 | $76.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 3 |
| Target Price | $52.86 | ★ $73.00 |
| AVG Volume (30 Days) | ★ 599.8K | 410.2K |
| Earning Date | 05-06-2026 | 06-17-2026 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | ★ 61.90 | 13.48 |
| EPS | N/A | ★ 1.32 |
| Revenue | $218,710,000.00 | ★ $1,819,519,000.00 |
| Revenue This Year | N/A | $6.92 |
| Revenue Next Year | $201.05 | $3.25 |
| P/E Ratio | ★ N/A | $58.16 |
| Revenue Growth | ★ 3024.43 | 12.20 |
| 52 Week Low | $25.36 | $58.27 |
| 52 Week High | $42.68 | $87.51 |
| Indicator | IDYA | KFY |
|---|---|---|
| Relative Strength Index (RSI) | 52.15 | 33.61 |
| Support Level | $35.11 | $66.62 |
| Resistance Level | $40.58 | $79.97 |
| Average True Range (ATR) | 1.13 | 2.22 |
| MACD | -0.21 | -0.83 |
| Stochastic Oscillator | 36.51 | 5.13 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.